Drugmakers leery of generic rival in trade group
Pharmaceutical lobbyists oppose Teva's move to join the Pharmaceutical Research and Manufacturers of America, saying that it is tantamount to allowing a spy into the fold
Washington
FOR decades, brand-name and generic drug companies have fought each other in Congress, at international trade negotiations and in court. So when the world's largest generic drug company moved this year to join the powerful trade association for producers of brand-name medicines, pharmaceutical lobbyists were in a swivet.
The trade group, the Pharmaceutical Research and Manufacturers of America, known as PhRMA, is plunging into battles over drug prices here and in many state capitols. And the request from the generic company, Teva Pharmaceutical Industries, is raising eyebrows in PhRMA's secretive councils.
Some brand-name drug companies have expressed alarm at the prospect that Teva will join th…
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Consumer & Healthcare
Gucci-owner Kering posts 10% drop in Q1 sales on sluggish Chinese demand
China bubble-tea chain Chabaidao plunges on Hong Kong debut
Japan’s 7-Eleven convenience chain targets aggressive global growth
Parental fury after stem cell bank ruins thousands of samples in Singapore
China’s bubble tea boom creates a half-dozen billionaires
US sues to block Coach owner’s US$8.5 billion buyout of Versace parent